1. HLA‐DQ2 is associated with anti‐drug antibody formation to infliximab in patients with immune‐mediated inflammatory diseases. (26th February 2023) Authors: Brun, Marthe Kirkesæther; Bjørlykke, Kristin Hammersbøen; Viken, Marte K.; Stenvik, Grethe‐Elisabeth; Klaasen, Rolf A.; Gehin, Johanna E.; Warren, David John; Sexton, Joseph; Sandanger, Øystein; Kvien, Tore K.; Mørk, Cato; Haavardsholm, Espen A.; Jahnsen, Jørgen; Goll, Guro Løvik; Lie, Benedicte ... Journal: Journal of internal medicine Issue: Volume 293:Number 5(2023) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. (26th April 2022) Authors: Brun, Marthe Kirkesæther; Goll, Guro Løvik; Jørgensen, Kristin Kaasen; Sexton, Joseph; Gehin, Johanna Elin; Sandanger, Øystein; Olsen, Inge Christoffer; Klaasen, Rolf Anton; Warren, David John; Mørk, Cato; Kvien, Tore K.; Jahnsen, Jørgen; Bolstad, Nils; Haavardsholm, Espen A.; Syversen, Silje Wat... Journal: Journal of internal medicine Issue: Volume 292:Number 3(2022) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Specific changes in conduction velocity recovery cycles of single nociceptors in a patient with erythromelalgia with the I848T gain-of-function mutation of Nav1.7. Issue 9 (September 2015) Authors: Namer, Barbara; Ørstavik, Kristin; Schmidt, Roland; Kleggetveit, Inge-Petter; Weidner, Christian; Mørk, Cato; Kvernebo, Mari Skylstad; Kvernebo, Knut; Salter, Hugh; Carr, Thomas Hedley; Segerdahl, Märta; Quiding, Hans; Waxman, Stephen George; Handwerker, Hermann Otto; Torebjörk, Hans Erik; Jørum,... Journal: Pain Issue: Volume 156:Issue 9(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial. Issue 10086 (10th June 2017) Authors: Jørgensen, Kristin K; Olsen, Inge C; Goll, Guro L; Lorentzen, Merete; Bolstad, Nils; Haavardsholm, Espen A; Lundin, Knut E A; Mørk, Cato; Jahnsen, Jørgen; Kvien, Tore K Journal: Lancet Issue: Volume 389:Issue 10086(2017) Page Start: 2304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. X linked mental retardation and infantile spasms in a family: new clinical data and linkage to Xp11.4-Xp22.11. Issue 5 (1st May 1999) Authors: Strømme, Petter; Sundet, Kjetil; Mørk, Cato; Cassiman, Jean-Jacques; Fryns, Jean-Pierre; Claes, Stephan Journal: Journal of medical genetics Issue: Volume 36:Issue 5(1999) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗